A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Cancers|Breast Cancer
Interventions: DRUG: CFI-402257|DRUG: Fulvestrant
Sponsor: University Health Network, Toronto